News

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...
Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...
In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...
"The developers expect to create Russia's first drug for multiple myeloma based on CAR-NK therapy. It is planned that the drug using the new technology will pass all the necessary clinical trials and ...
A New York City federal court has dismissed a proposed class-action lawsuit against Bristol Myers Squibb that accused the ...
A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance ...
Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...
Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible ...